Anna Moskal is a Team Leader and Process Engineer who works on the Upstream Drug Substance part of the Manufacturing Department. Her expertise includes early-stage upstream activities such as inoculum expansion and cell banking, as well as cell culture in bioreactor systems. She collaborates on technology transfer initiatives and process validation efforts, helping to ensure efficient scale-up and reliable production processes for clinical development and commercial manufacturing.
Articles
Topic
Type
